Events and
Presentations

March 8, 2019 4:30 PM EST : Conatus Pharmaceuticals Fourth Quarter 2018 Financial Results
Open Webcast
March 08

View All

Our
Programs

Emricasan is a first-in-class, orally active caspase inhibitor designed to reduce the activity of ...

Learn More